Mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ

Diabetes mellitus (DM) is concomitant with significant morbidity and mortality and its prevalence is accumulative in worldwide. The conventional antidiabetic agents are known to mitigate the symptoms of diabetes; however, they may also cause side and adverse effects. There is an imperative necessity...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sih-Pei Chen, Shian-Ren Lin, Ting-Hsu Chen, Hui-Suan Ng, Hip-Seng Yim, Max K. Leong, Ching-Feng Weng
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/4e4f22de34fa41f6b02b82a8d0a0d198
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4e4f22de34fa41f6b02b82a8d0a0d198
record_format dspace
spelling oai:doaj.org-article:4e4f22de34fa41f6b02b82a8d0a0d1982021-11-14T04:29:54ZMangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ0753-332210.1016/j.biopha.2021.112333https://doaj.org/article/4e4f22de34fa41f6b02b82a8d0a0d1982021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0753332221011173https://doaj.org/toc/0753-3322Diabetes mellitus (DM) is concomitant with significant morbidity and mortality and its prevalence is accumulative in worldwide. The conventional antidiabetic agents are known to mitigate the symptoms of diabetes; however, they may also cause side and adverse effects. There is an imperative necessity to conduct preclinical and clinical trials for the discovery of alternative therapeutic agents that can overcome the drawbacks of current synthetic antidiabetic drugs. This study aimed to investigate the efficacy of lowering blood glucose and underlined mechanism of γ-mangostin, mangosteen (Garcinia mangostana) xanthones. The results showed γ-Mangostin had a antihyperglycemic ability in short (2 h)- and long-term (28 days) administrations to diet-induced diabetic mice. The long-term administration of γ-mangostin attenuated fasting blood glucose of diabetic mice and exhibited no hepatotoxicity and nephrotoxicity. Moreover, AMPK, PPARγ, α-amylase, and α-glucosidase were found to be the potential targets for simulating binds with γ-mangostin after molecular docking. To validate the docking results, the inhibitory potency of γ-mangostin againstα-amylase/α-glucosidase was higher than Acarbose via enzymatic assay. Interestingly, an allosteric relationship between γ-mangostin and insulin was also found in the glucose uptake of VSMC, FL83B, C2C12, and 3T3-L1 cells. Taken together, the results showed that γ-mangostin exerts anti-hyperglycemic activity through promoting glucose uptake and reducing saccharide digestion by inhibition of α-amylase/α-glucosidase with insulin sensitization, suggesting that γ-mangostin could be a new clue for drug discovery and development to treat diabetes.Sih-Pei ChenShian-Ren LinTing-Hsu ChenHui-Suan NgHip-Seng YimMax K. LeongChing-Feng WengElsevierarticleDiabetesInsulin resistanceGarcinia mangostanaGamma-mangostinComputer simulationTherapeutics. PharmacologyRM1-950ENBiomedicine & Pharmacotherapy, Vol 144, Iss , Pp 112333- (2021)
institution DOAJ
collection DOAJ
language EN
topic Diabetes
Insulin resistance
Garcinia mangostana
Gamma-mangostin
Computer simulation
Therapeutics. Pharmacology
RM1-950
spellingShingle Diabetes
Insulin resistance
Garcinia mangostana
Gamma-mangostin
Computer simulation
Therapeutics. Pharmacology
RM1-950
Sih-Pei Chen
Shian-Ren Lin
Ting-Hsu Chen
Hui-Suan Ng
Hip-Seng Yim
Max K. Leong
Ching-Feng Weng
Mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ
description Diabetes mellitus (DM) is concomitant with significant morbidity and mortality and its prevalence is accumulative in worldwide. The conventional antidiabetic agents are known to mitigate the symptoms of diabetes; however, they may also cause side and adverse effects. There is an imperative necessity to conduct preclinical and clinical trials for the discovery of alternative therapeutic agents that can overcome the drawbacks of current synthetic antidiabetic drugs. This study aimed to investigate the efficacy of lowering blood glucose and underlined mechanism of γ-mangostin, mangosteen (Garcinia mangostana) xanthones. The results showed γ-Mangostin had a antihyperglycemic ability in short (2 h)- and long-term (28 days) administrations to diet-induced diabetic mice. The long-term administration of γ-mangostin attenuated fasting blood glucose of diabetic mice and exhibited no hepatotoxicity and nephrotoxicity. Moreover, AMPK, PPARγ, α-amylase, and α-glucosidase were found to be the potential targets for simulating binds with γ-mangostin after molecular docking. To validate the docking results, the inhibitory potency of γ-mangostin againstα-amylase/α-glucosidase was higher than Acarbose via enzymatic assay. Interestingly, an allosteric relationship between γ-mangostin and insulin was also found in the glucose uptake of VSMC, FL83B, C2C12, and 3T3-L1 cells. Taken together, the results showed that γ-mangostin exerts anti-hyperglycemic activity through promoting glucose uptake and reducing saccharide digestion by inhibition of α-amylase/α-glucosidase with insulin sensitization, suggesting that γ-mangostin could be a new clue for drug discovery and development to treat diabetes.
format article
author Sih-Pei Chen
Shian-Ren Lin
Ting-Hsu Chen
Hui-Suan Ng
Hip-Seng Yim
Max K. Leong
Ching-Feng Weng
author_facet Sih-Pei Chen
Shian-Ren Lin
Ting-Hsu Chen
Hui-Suan Ng
Hip-Seng Yim
Max K. Leong
Ching-Feng Weng
author_sort Sih-Pei Chen
title Mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ
title_short Mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ
title_full Mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ
title_fullStr Mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ
title_full_unstemmed Mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ
title_sort mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of ampk/pparγ
publisher Elsevier
publishDate 2021
url https://doaj.org/article/4e4f22de34fa41f6b02b82a8d0a0d198
work_keys_str_mv AT sihpeichen mangosteenxanthonegmangostinexertsloweringbloodglucoseeffectwithpotentiatinginsulinsensitivitythroughthemediationofampkpparg
AT shianrenlin mangosteenxanthonegmangostinexertsloweringbloodglucoseeffectwithpotentiatinginsulinsensitivitythroughthemediationofampkpparg
AT tinghsuchen mangosteenxanthonegmangostinexertsloweringbloodglucoseeffectwithpotentiatinginsulinsensitivitythroughthemediationofampkpparg
AT huisuanng mangosteenxanthonegmangostinexertsloweringbloodglucoseeffectwithpotentiatinginsulinsensitivitythroughthemediationofampkpparg
AT hipsengyim mangosteenxanthonegmangostinexertsloweringbloodglucoseeffectwithpotentiatinginsulinsensitivitythroughthemediationofampkpparg
AT maxkleong mangosteenxanthonegmangostinexertsloweringbloodglucoseeffectwithpotentiatinginsulinsensitivitythroughthemediationofampkpparg
AT chingfengweng mangosteenxanthonegmangostinexertsloweringbloodglucoseeffectwithpotentiatinginsulinsensitivitythroughthemediationofampkpparg
_version_ 1718430011229208576